<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="fcfc9676-4edc-460e-6199-8161b824908f"><labelDrug name="TENORMIN"><Normalization><mmtx cui="C0592168" preferredWord="Tenormin" semType="phsu, orch"/></Normalization></labelDrug><generic name="Atenolol"/><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.1" text="TENORMIN (atenolol) tablet" type="negative"><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.1.e.0" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="10:18" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.1.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="(atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.1.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.1.e.1"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.2" text="TENORMIN  (atenolol), a synthetic, beta1-selective (cardioselective) adrenoreceptor blocking agent" type="negative"><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.2.e.0" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="11:19" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.2.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="(atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.2.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.2.e.1"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6" text="TENORMIN is contraindicated in those patients with a history of hypersensitivity to the atenolol or any of the drug product s components." type="negative"><entity charOffset="111:123" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.0" text="drug product" type="Biomedical_Entity"><Normalization><mmtx cui="C0013227" phraseText="any of the drug product s components." preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="88:96" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="to the atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.2" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.6.e.1"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.10" text="In patients with acute myocardial infarction, cardiac failure which is not promptly and effectively controlled by 80 mg of intravenous furosemide or equivalent therapy is a contraindication to beta-blocker treatment." type="negative"><entity charOffset="193:205" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.10.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="a contraindication to beta-blocker treatment." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="114:145" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.10.e.1" text="80 mg furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0992359" phraseText="controlled by 80 mg of intravenous furosemide" preferredWord="Furosemide 80 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.10.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.10.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.20" text="As with other beta blockers, when discontinuation of TENORMIN is planned, the patients should be carefully observed and advised to limit physical activity to a minimum. " type="negative"><entity charOffset="53:61" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.20.e.0" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="discontinuation of TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="14:27" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.20.e.1" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="As with other beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.20.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.20.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25" lineNumber="29" text="Bradycardia and heart block can occur and the left ventricular end diastolic pressure can rise when beta-blockers are administered with verapamil or diltiazem. " type="regular"><entity charOffset="100:113" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.0" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="136:145" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="administered with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="149:158" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.2" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem." preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.3" text="Bradycardia" type="Specific_Interaction"/><entity charOffset="16:27" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.5" text="heart block" type="Specific_Interaction"/><entity charOffset="46:94" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.7" text="left ventricular end diastolic pressure can rise" type="Specific_Interaction"/><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.ddi.2"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.ddi.3"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.1" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.2" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.25.e.2"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.30" text="Because of its relative beta1 selectivity, however, TENORMIN may be used with caution in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. " type="negative"><entity charOffset="175:191" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.30.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive treatment." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="52:60" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.30.e.1" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.30.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.30.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.31" text="Since beta1 selectivity is not absolute, the lowest possible dose of TENORMIN should be used with therapy initiated at 50 mg and a beta2-stimulating agent (bronchodilator) should be made available. " type="negative"><entity charOffset="156:170" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.31.e.0" text="bronchodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C0006280" phraseText="(bronchodilator" preferredWord="Bronchodilator Agents" semType="phsu"/><RxNorm RxCui="1779"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.31.e.1" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="the lowest possible dose of TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.31.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.31.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.36" text="TENORMIN should be used with caution in diabetic patients if a beta-blocking agent is required. " type="negative"><entity charOffset="63:82" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.36.e.0" text="beta-blocking agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="a beta-blocking agent" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.36.e.1" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.36.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.36.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38" text="At recommended doses TENORMIN does not potentiate insulin-induced hypoglycemia and, unlike nonselective beta blockers, does not delay recovery of blood glucose to normal levels." type="negative"><entity charOffset="152:159" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.0" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="recovery of blood glucose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="21:29" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.1" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="At recommended doses TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="104:117" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.2" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="unlike nonselective beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.38.e.2"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.55" text="Atenolol has been shown to produce a dose-related increase in embryo/fetal resorptions in rats at doses equal to or greater than 50 mg/kg/day or 25 or more times the maximum recommended human antihypertensive dose1. " type="negative"><entity charOffset="192:208" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.55.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="human antihypertensive dose1." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.55.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="Atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.55.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.55.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.59" text="Patients already on a beta blocker must be evaluated carefully before TENORMIN is administered. " type="negative"><entity charOffset="70:78" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.59.e.0" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="22:34" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.59.e.1" text="beta blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Patients already on a beta blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.59.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.59.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66" lineNumber="71" text="Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents. " type="regular"><entity charOffset="0:29" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.0" text="Catecholamine-depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="Catecholamine-depleting drugs" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="Catecholamine-depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="Catecholamine-depleting drugs" preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="Catecholamine-depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="990350"/></Normalization></entity><entity charOffset="35:44" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.1" text="reserpine" type="Drug"><Normalization><mmtx cui="C0035179" phraseText="reserpine" preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="58:73" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.3" text="additive effect" type="Increase_Interaction"/><entity charOffset="90:110" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.5" text="beta-blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="given with beta-blocking agents." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugClassMembership drug="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.1" drugClass="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.0"/><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.5" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.66.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67" lineNumber="71" text="Patients treated with TENORMIN plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension." type="regular"><entity charOffset="114:125" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.0" text="hypotension" type="Specific_Interaction"/><entity charOffset="140:151" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.2" text="bradycardia" type="Specific_Interaction"/><entity charOffset="22:30" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.4" text="TENORMIN" type="Drug"><Normalization><mmtx cui="C0592168" phraseText="treated with TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="38:60" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.5" text="catecholamine depletor" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="plus a catecholamine depletor" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C3536742" phraseText="plus a catecholamine depletor" preferredWord="Catecholamine [EPC]" semType="phsu"/><RxNorm RxCui="1451215"/></Normalization></entity><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.0"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.ddi.2"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.2"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.4" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.5" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.67.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68" lineNumber="73" text="Calcium channel blockers may also have an additive effect when given with TENORMIN (See WARNINGS)." type="regular"><entity charOffset="0:24" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.0" text="Calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="Calcium channel blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="42:57" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.1" text="additive effect" type="Increase_Interaction"/><entity charOffset="74:82" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.3" text="TENORMIN" type="Drug"><Normalization><mmtx cui="C0592168" phraseText="given with TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.3" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.68.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.69" text="Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects. " type="negative"><entity charOffset="0:12" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.69.e.0" text="disopyramide" type="Biomedical_Entity"><Normalization><mmtx cui="C0012702" phraseText="Disopyramide" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="25:44" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.69.e.1" text="antiarrhythmic drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="a Type I antiarrhythmic drug with potent negative inotropic" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.69.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.69.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70" lineNumber="75" text="Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers." type="regular"><entity charOffset="0:12" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.0" text="Disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="Disopyramide" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="45:56" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.1" text="bradycardia" type="Specific_Interaction"/><entity charOffset="58:66" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.3" text="asystole" type="Specific_Interaction"><Normalization><mmtx cui="C0018790" phraseText="asystole" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="71:84" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.5" text="heart failure" type="Specific_Interaction"><Normalization><mmtx cui="C0018801" phraseText="heart failure" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="108:121" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.7" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="administered with beta blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.1"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.ddi.2"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.3"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.ddi.3"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.5"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.7" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.70.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71" lineNumber="77" text="Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers." type="regular"><entity charOffset="0:10" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.0" text="Amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="Amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="17:37" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.1" text="antiarrhythmic agent" type="Drug_Class"><Normalization><mmtx cui="C0003195" phraseText="an antiarrhythmic agent with negative chronotropic properties" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="43:75" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.3" text="negative chronotropic properties" type="Specific_Interaction"/><entity charOffset="116:129" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.5" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="seen with beta blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.0" drugClass="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.1"/><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.3"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.5" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.71.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72" lineNumber="79" text="Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. " type="regular"><entity charOffset="0:13" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.0" text="Beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="33:53" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.1" text="rebound hypertension" type="Specific_Interaction"><Normalization><mmtx cui="C0520540" phraseText="the rebound hypertension" preferredWord="Rebound hypertension" semType="dsyn"/></Normalization></entity><entity charOffset="89:98" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.3" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="the withdrawal of clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.1"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.3" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.72.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73" lineNumber="79" text="If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine. " type="regular"><entity charOffset="64:73|87:93" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.0" text="withdrawn before" type="Caution_Interaction"/><entity charOffset="120:129" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="several days before the gradual withdrawal of clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="41:53" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.3" text="beta blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="the beta blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.3" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.2" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.73.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74" text="If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped." type="negative"><entity charOffset="68:81" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the introduction of beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:38" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="replacing clonidine by beta-blocker therapy," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.2" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="replacing clonidine by beta-blocker therapy," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="123:132" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.3" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="after clonidine administration" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.1"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.74.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75" lineNumber="81" text="Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers." type="regular"><entity charOffset="19:58" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.0" text="prostaglandin synthase inhibiting drugs" type="Drug_Class"><Normalization><mmtx cui="C0033554" phraseText="Concomitant use of prostaglandin synthase inhibiting drugs," preferredWord="Prostaglandins" semType="eico, bacs, phsu"/><mmtx cui="C0013227" phraseText="Concomitant use of prostaglandin synthase inhibiting drugs," preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="8803"/></Normalization></entity><entity charOffset="64:76" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.1" text="indomethacin" type="Drug"><Normalization><mmtx cui="C0021246" phraseText="indomethacin," preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="82:114" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.2" text="decrease the hypotensive effects" type="Specific_Interaction"/><entity charOffset="118:131" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.4" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="the hypotensive effects of beta blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.1" drugClass="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.0"/><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.2"><relations><relation type="hasObject"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.4" trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.75.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.76" text="Information on concurrent usage of atenolol and aspirin is limited. " type="negative"><entity charOffset="48:55" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.76.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="35:43" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.76.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="Information on concurrent usage of atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.76.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.76.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.77" text="Data from several studies, ie, TIMI-II, ISIS-2, currently do not suggest any clinical interaction between aspirin and beta blockers in the acute myocardial infarction setting." type="negative"><entity charOffset="118:131" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.77.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers in the acute myocardial infarction setting." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="106:113" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.77.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="any clinical interaction between aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.77.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.77.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.78" text="While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic. " type="negative"><entity charOffset="93:102" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.78.e.0" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="13:26" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.78.e.1" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.78.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.78.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="5:25" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80.e.0" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="30:43" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.81" lineNumber="87" text="Concomitant use can increase the risk of bradycardia." type="irregular"><entity charOffset="41:52" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.81.e.0" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.81.ddi.1"><interaction trigger="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.81.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="5:25" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80.e.0" text="digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="30:43" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.80.e.1" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87" text="Chronic studies employing oral atenolol performed in animals have revealed the occurrence of vacuolation of epithelial cells of Brunner's glands in the duodenum of both male and female dogs at all tested dose levels of atenolol (starting at 15 mg/kg/day or 7.5 times the maximum recommended human antihypertensive dose11, respectively)." type="negative"><entity charOffset="297:313" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="human antihypertensive dose11," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="219:227" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="female dogs at all tested dose levels of atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="31:39" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.2" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="oral atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.87.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.92" text="Atenolol is excreted in human breast milk at a ratio of 1.5 to 6.8 when compared to the concentration in plasma. " type="negative"><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.92.e.0" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="Atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="24:41" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.92.e.1" text="human breast milk" type="Biomedical_Entity"><Normalization><mmtx cui="C0885503" phraseText="excreted in human breast milk" preferredWord="human breast milk" semType="phsu, orch"/><RxNorm RxCui="831503"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.92.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.92.e.1"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.113" text="The initial dose of TENORMIN is 50 mg given as one tablet a day either alone or added to diuretic therapy. " type="negative"><entity charOffset="20:28" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.113.e.0" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="The initial dose of TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="89:97" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.113.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="added to diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.113.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.113.e.1"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117" text="TENORMIN may be used alone or concomitantly with other antihypertensive agents including thiazide-type diuretics, hydralazine, prazosin, and alpha-methyldopa." type="negative"><entity charOffset="89:112" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.0" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="thiazide-type diuretics," preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.1" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="127:135" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.2" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="prazosin," preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="141:157" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.3" text="alpha-methyldopa" type="Biomedical_Entity"><Normalization><mmtx cui="C0025741" phraseText="alpha-methyldopa." preferredWord="Methyldopa" semType="phsu, aapp, nsba"/><RxNorm RxCui="6876"/></Normalization></entity><entity charOffset="114:125" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.4" text="hydralazine" type="Biomedical_Entity"><Normalization><mmtx cui="C0020223" phraseText="hydralazine," preferredWord="Hydralazine" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><entity charOffset="55:78" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.5" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="concomitantly with other antihypertensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.2"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.4"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.5" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.2"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.4"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.5"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.4" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.2"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.5" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.2"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.4" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.5" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.5" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.117.e.4"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132" text="Injection in Dextrose Injection USP, Sodium Chloride Injection USP, or Sodium Chloride and Dextrose Injection may be used. " type="negative"><entity charOffset="37:62" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.0" text="sodium chloride injection" type="Biomedical_Entity"><Normalization><mmtx cui="C2092279" phraseText="Sodium Chloride Injection USP," preferredWord="sodium chloride injection" semType="clnd"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="71:86" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.1" text="sodium chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0037494" phraseText="Sodium Chloride" preferredWord="Sodium Chloride" semType="bacs, inch, phsu"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="13:21" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.2" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="Injection in Dextrose Injection USP," preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="91:99" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.3" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="Dextrose Injection" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.1"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.0" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.3"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.1"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.132.e.3"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138" text="Data from other beta blocker trials suggest that if there is any question concerning the use of IV beta blocker or clinical estimate that there is a contraindication, the IV beta blocker may be eliminated and patients fulfilling the safety criteria may be given TENORMIN Tablets 50 mg twice daily or 100 mg once a day for at least seven days (if the IV dosing is excluded)." type="negative"><entity charOffset="262:278" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.0" text="tenormin tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1241634" phraseText="TENORMIN Tablets 50 mg twice daily" preferredWord="Atenolol Oral Tablet [Tenormin]" semType="clnd"/><RxNorm RxCui="152413"/></Normalization></entity><entity charOffset="16:28" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.1" text="beta blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Data from other beta blocker trials" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="99:111" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.2" text="beta blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the use of IV beta blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="174:186" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.3" text="beta blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the IV beta blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.1" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.3" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.138.e.0"/></sentence><sentence id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139" text="Although the demonstration of efficacy of TENORMIN is based entirely on data from the first seven postinfarction days, data from other beta blocker trials suggest that treatment with beta blockers that are effective in the postinfarction setting may be continued for one to three years if there are no contraindications." type="negative"><entity charOffset="183:196" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="that treatment with beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="135:147" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.1" text="beta blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="data from other beta blocker trials" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="42:50" id="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.2" text="tenormin" type="Biomedical_Entity"><Normalization><mmtx cui="C0592168" phraseText="the demonstration of efficacy of TENORMIN" preferredWord="Tenormin" semType="phsu, orch"/><RxNorm RxCui="152413"/></Normalization></entity><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.0"/><pair ddi="false" e1="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.2" e2="Dailymed.fcfc9676-4edc-460e-6199-8161b824908f.s.139.e.1"/></sentence><positiveExamples number="10"/><negativeExamples number="54"/></document>